Emerging Macrolide Resistance in Mycoplasma pneumoniae in Children
- 1 August 2009
- journal article
- case report
- Published by Wolters Kluwer Health in The Pediatric Infectious Disease Journal
- Vol. 28 (8) , 693-696
- https://doi.org/10.1097/inf.0b013e31819e3f7a
Abstract
Epidemiologic data from Asia have documented the rapid and extensive emergence of macrolide resistance in Mycoplasma pneumoniae. This drug resistance has also been documented in Europe and recently in the United States, but there is very little information currently available on its prevalence. A rapid technique to identify macrolide-resistant M. pneumoniae is needed to guide management of patients with community-acquired respiratory infections. Culture and Minimum Inhibitory Concentration testing identified macrolide-resistant M. pneumoniae infection in 2 seriously ill hospitalized children with community-acquired pneumonia. A portion of the 23S ribosomal RNA gene from 2 macrolide-resistant M. pneumoniae isolates from these children as well as 4 laboratory-induced macrolide-resistant strains was amplified by PCR, and the PCR products were sequenced to identify mutations associated with macrolide resistance. A real-time PCR assay was designed to identify 3 known mutations in the 23S rRNA gene associated with macrolide resistance and applied to the clinical specimens from which these isolates were obtained and to the bacterial isolates. Macrolide-resistant M. pneumoniae from both children were found to carry an A2063G transition in the 23S rRNA gene previously identified in resistant isolates from China, Japan, France, and recently in an encephalitis outbreak in Rhode Island. Three laboratory-induced mutant strains had an A2064G mutation whereas the other one had an A2063G mutation. A real-time PCR assay successfully detected the macrolide-resistant M. pneumoniae directly in clinical specimens and discriminated them from wild-type isolates. Macrolide-resistant M. pneumoniae can be associated with prolonged severe respiratory infection in children. Real-time PCR offers a rapid method of diagnosing macrolide resistance in community-acquired respiratory infections due to M. pneumoniae.Keywords
This publication has 13 references indexed in Scilit:
- Antimicrobial Susceptibility of Mycoplasma pneumoniae Isolates and Molecular Analysis of Macrolide-Resistant Strains from Shanghai, ChinaAntimicrobial Agents and Chemotherapy, 2009
- Increased Macrolide Resistance of Mycoplasma pneumoniae in Pediatric Patients with Community-Acquired PneumoniaAntimicrobial Agents and Chemotherapy, 2008
- First Report of Macrolide-Resistant Strains and Description of a Novel Nucleotide Sequence Variation in the P1 Adhesin Gene in Mycoplasma pneumoniae Clinical Strains Isolated in France over 12 YearsJournal of Clinical Microbiology, 2007
- Clinical Evaluation of Macrolide-Resistant Mycoplasma pneumoniaeAntimicrobial Agents and Chemotherapy, 2006
- Emergence of Macrolide-Resistant Mycoplasma pneumoniae with a 23S rRNA Gene MutationAntimicrobial Agents and Chemotherapy, 2005
- Characterization and Molecular Analysis of Macrolide-Resistant Mycoplasma pneumoniae Clinical Isolates Obtained in JapanAntimicrobial Agents and Chemotherapy, 2004
- Mycoplasma pneumoniaeand Its Role as a Human PathogenClinical Microbiology Reviews, 2004
- Incidence of community‐acquired pneumonia in children caused by Mycoplasma pneumoniae: Serological results of a prospective, population‐based study in primary health careRespirology, 2004
- Characteristics of Macrolide‐Resistant Mycoplasma pneumoniae Strains Isolated from Patients and Induced with Erythromycin In VitroMicrobiology and Immunology, 2001
- Incidence of Upper Respiratory Tract Mycoplasma pneumoniae Infections among Outpatients in Rhône-Alpes, France, during Five Successive Winter PeriodsJournal of Clinical Microbiology, 1999